About Insilico Biotechnology
Insilico Biotechnology is a Healthcare company based in Stuttgart (Germany) founded in 2001, and was acquired by Yokogawa in November 2021. In silico cell models are simulated for drug discovery. Its focus areas include HealthTech, Life Sciences Tech, Diversified and Life Sciences. Its legal entity is Insilico Biotechnology AG.
Company details
Insilico Biotechnology was founded in 2001 in Stuttgart, Germany, within the insilico biotechnology sector. Software solutions such as Insilico Inspector for bioprocess diagnosis, Insilico Discovery for cellular network verification, and Insilico Cells for genome-based models are offered. Customized services in cell line engineering, process optimization, pharmaceutical testing, and de novo cellular network reconstruction are provided, including consulting on media development, clone selection, upscale strategies, and drug effect predictions.
- Headquarters Stuttgart, Germany
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website insilico-biotechnology.com
- Social LinkedIn X
- Acquired by Yokogawa (Nov 2021)
- Legal Name Insilico Biotechnology Ag
Funding Insights of Insilico Biotechnology
- Total Rounds 2
- Last Round Grant β $281,440
- First Round $342,500
(Jul 2007)
- Investors Count 1
All 2 funding rounds of Insilico Biotechnology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2015 | $281,440 | Grant | β | β | β |
| Jul 2007 | $342,500 | Grant | β | β |
2 investors in total: 2 institutional.
Investors in Insilico Biotechnology
Insilico Biotechnology has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Yokogawa and BMBF.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Education and research policies are overseen by the ministry. | 1955 | bmbf.de | Berlin, Germany | |
Cloud-based industrial automation and process control solutions are offered. | 1915 | yokogawa.com | Tokyo, Japan |
Investor details for Insilico Biotechnology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Insilico Biotechnology
8 people are tracked at Insilico Biotechnology (3 in leadership, 5 in team).
| Name | Role | Group |
|---|---|---|
Yasuhito Murato | Managing Director Operations | Leadership |
Brett Lepore | President | Leadership |
Jakob Kirch | Head of Modeling and Simulation | Leadership |
Atul Mahadev Vhanmarathi | Data Scientist | Team |
Lukas Nortmann | Wissenschaftlicher Programmierer | Team |
Amin Mirzaei, PhD | Senior Data Scientist | Team |
Joachim Bucher | Senior Data Scientist | Team |
Maike Naber | Senior Software Entwickler:in | Team |
Complete people profiles for Insilico Biotechnology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Insilico Biotechnology
4 dated milestones of Insilico Biotechnology across 20 years, from founding to its latest funding, stage changes and deals.
- Founded Insilico Biotechnology is founded.
- Funding First funding round of $342K.
- Funding Latest funding round, Grant, of $281K.
- Exit Acquired by Yokogawa.
Web traffic of Insilico Biotechnology
The website of Insilico Biotechnology (insilico-biotechnology.com) receives about 2K visits a month.
- Monthly visits2K
▼ 1.6% vs previous month
Websites whose visitors overlap most with Insilico Biotechnology. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| bluetractorsoftware.co.uk | 100% | View details | |||
softzymics.com | softzymics.com | 100% | β | ||
| ludesi.com | 100% | View details | |||
broad.mit.edu | broad.mit.edu | 100% | β | ||
| phenosystems.com | 100% | 680.7K | #13,325,283 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 10 similar websites and full traffic analytics for Insilico Biotechnology
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Insilico Biotechnology
Complete news archive for Insilico Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Insilico Biotechnology
Insilico Biotechnology was founded in 2001 and raised its 1st funding round 6 years after it was founded.
Insilico Biotechnology is headquartered in Stuttgart, Germany. It is registered at Stuttgart, Baden-wurttemberg, Germany.
Insilico Biotechnology was founded in 2001 in Stuttgart, Germany, within the insilico biotechnology sector. Software solutions such as Insilico Inspector for bioprocess diagnosis, Insilico Discovery for cellular network verification, and Insilico Cells for genome-based models are offered. Customized services in cell line engineering, process optimization, pharmaceutical testing, and de novo cellular network reconstruction are provided, including consulting on media development, clone selection, upscale strategies, and drug effect predictions.
Insilico Biotechnology operates through Insilico Biotechnology Ag.
Yes. Insilico Biotechnology was acquired by Yokogawa in November 2021.

